The global antitussive drugs market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The market growth is majorly attributed to the growing prevalence of cough, pulmonary disorders such as chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis, and lung cancer all over the globe. Further, the switch from prescription to OTC category, and a rise in the rise geriatric population are anticipated to drive the market. However, the competition faced by international players due to drugs from local manufacturers and natural remedies restrain the market growth. Favorable regulations and opportunities in the emerging economies of Asia-Pacific and Latin America Middle East and Africa due to the availability of large patient pools provide promising growth opportunities for the market growth. 

Some common causes of cough include asthma, consumption of tobacco, postnasal drip, and gastroesophageal reflux disease (GERD). Numerous types of conditions are susceptible to cause chronic cough if not treated properly. Major signs and symptoms include frequent throat clearing & sore throat, runny or stuffy nose, hoarseness, wheezing, and shortness of breath. Other causes of cough include chronic obstructive pulmonary disease (COPD), pneumonia, bronchiectasis, non-asthmatic eosinophilic bronchitis bronchiolitis, lung cancer, idiopathic pulmonary fibrosis, and usage of blood pressure drugs. Further, the outbreak of COVID-19 had also boosted the sale of various antitussive drugs. Apart from these factors, an increase in vehicle pollution, and growth in the development of R&D activities, among other factors are anticipated to propel the global antitussive drugs market during the forecast period. 

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028

Segment Covered- 

• By Drug Class
• By Route of Administration
• By Distribution Channel 

Regions covered-

• North America
• Europe
• Asia-Pacific
• Rest of the World

Competitive Landscape:  Pfizer Inc., Merck & Co., Inc., and Novartis International AG, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Antitussive Drugs Market Report by Segment

By Drug Class

• Centrally Acting Drugs
• Peripherally Acting Drugs
• Others

By Route of Administration

• Oral
• Inhalation
• Others

By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Others

Global Antitussive Drugs Market Report by Region

North America       

• US
• Canada

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific    

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East and Africa